Humacyte Inc

NASDAQ:HUMA 1:22:48 PM EDT

12.77

-0.48 (-3.62%)

Market Cap (Intraday)	1.32B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.31 Million
Adjusted EPS	-$0.21

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Humacyte Inc Stock, NASDAQ:HUMA

2525 East North Carolina Highway 54, Durham, North Carolina 27713

United States of America

Phone: +1.919.313.9633

Number of Employees:

http://humacyte.com

Description

Humacyte, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason and Juliana L. Blum in October 13, 2004 and is headquartered in Durham, NC.